Pilot study to prevent a thin endometrium in patients undergoing clomiphene citrate treatment

Pilot study to prevent a thin endometrium in patients undergoing clomiphene citrate treatment - prevent a thin endometrium

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007959

Enrollment

Registered

2012-05-15

Start date

2012-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

patients who were given 50mg/day clomiphene citrate on days 5-9(standard treatment, control group) patients who were given 25mg/day clomiphene citrate on days 5-9(half-dose group) patients who were

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients who diagnosed as having a thin endometrium(<8mm) during the standard clomiphene citrate treatment cycle were recruited in this study

Exclusion criteria

Exclusion criteria: Patients were excluded if they had myoma, adenomyosis, congenital uterine anomaly, or ovarian tumors. Patients were also excluded if they used estrogens, progesterone, androgens, or had chronic use of any medication, including nonsteroidial anti-inflammatory agents.

Design outcomes

Primary

Measure	Time frame
Endometrial thickness at the induction of ovulation was assessed by ultrasonography.	—

Countries

Japan

Contacts

Public Contactakihisa takasaki

Saiseikai Shimonoseki General Hospital Department of Obstetrics and Gynecology

a-takasaki@simo.saiseikai.or.jp0832622300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026